385 related articles for article (PubMed ID: 15585834)
1. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
Li D; Gál I; Vermes C; Alegre ML; Chong AS; Chen L; Shao Q; Adarichev V; Xu X; Koreny T; Mikecz K; Finnegan A; Glant TT; Zhang J
J Immunol; 2004 Dec; 173(12):7135-9. PubMed ID: 15585834
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
Zhang J; Bárdos T; Li D; Gál I; Vermes C; Xu J; Mikecz K; Finnegan A; Lipkowitz S; Glant TT
J Immunol; 2002 Sep; 169(5):2236-40. PubMed ID: 12193687
[TBL] [Abstract][Full Text] [Related]
3. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL
J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409
[TBL] [Abstract][Full Text] [Related]
4. Differential control of CD28-regulated in vivo immunity by the E3 ligase Cbl-b.
Krawczyk CM; Jones RG; Atfield A; Bachmaier K; Arya S; Odermatt B; Ohashi PS; Penninger JM
J Immunol; 2005 Feb; 174(3):1472-8. PubMed ID: 15661906
[TBL] [Abstract][Full Text] [Related]
5. CD28-independent costimulation of T cells in alloimmune responses.
Yamada A; Kishimoto K; Dong VM; Sho M; Salama AD; Anosova NG; Benichou G; Mandelbrot DA; Sharpe AH; Turka LA; Auchincloss H; Sayegh MH
J Immunol; 2001 Jul; 167(1):140-6. PubMed ID: 11418642
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism.
Engelhardt JJ; Sullivan TJ; Allison JP
J Immunol; 2006 Jul; 177(2):1052-61. PubMed ID: 16818761
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
DiPaolo RJ; Unanue ER
J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
[TBL] [Abstract][Full Text] [Related]
8. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
9. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
10. The role of B7 costimulation in CD4/CD8 T cell homeostasis.
Yu X; Fournier S; Allison JP; Sharpe AH; Hodes RJ
J Immunol; 2000 Apr; 164(7):3543-53. PubMed ID: 10725709
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody.
Vanhove B; Laflamme G; Coulon F; Mougin M; Vusio P; Haspot F; Tiollier J; Soulillou JP
Blood; 2003 Jul; 102(2):564-70. PubMed ID: 12649149
[TBL] [Abstract][Full Text] [Related]
12. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection.
Buhlmann JE; Elkin SK; Sharpe AH
J Immunol; 2003 Jun; 170(11):5421-8. PubMed ID: 12759417
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.
Wu Y; Guo Y; Huang A; Zheng P; Liu Y
J Exp Med; 1997 Apr; 185(7):1327-35. PubMed ID: 9104819
[TBL] [Abstract][Full Text] [Related]
14. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
[TBL] [Abstract][Full Text] [Related]
15. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
16. Absence of B7-dependent responses in CD28-deficient mice.
Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
[TBL] [Abstract][Full Text] [Related]
17. Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4.
Walker LS; Wiggett HE; Gaspal FM; Raykundalia CR; Goodall MD; Toellner KM; Lane PJ
J Immunol; 2003 Jan; 170(1):91-8. PubMed ID: 12496387
[TBL] [Abstract][Full Text] [Related]
18. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
Dahlén E; Hedlund G; Dawe K
J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of T-cell activation by CD28 and CTLA-4].
Nagel T; Kalden JR; Manger B
Med Klin (Munich); 1998 Oct; 93(10):592-7. PubMed ID: 9849050
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
